Valuation: BioGaia AB

Market Cap 12.63B 1.3B 1.14B 1.06B 971M 1.83B 126B 1.86B 4.95B 61.49B 4.89B 4.79B 212B P/E 2026 *
30.8x
P/E 2027 * 25.6x
Enterprise Value 11.93B 1.23B 1.08B 998M 918M 1.73B 119B 1.76B 4.68B 58.11B 4.62B 4.52B 200B EV / Sales 2026 *
7.12x
EV / Sales 2027 * 6.36x
Free-Float
80.82%
Yield 2026 *
3.37%
Yield 2027 * 3.61%
1 day-4.45%
1 week+1.62%
Current month+1.80%
1 month+2.76%
3 months-2.86%
6 months+10.08%
Current year+12.05%
1 week 113.8
Extreme 113.8
128.4
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 45.8
Extreme 45.8
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Director

582 0.0006%
12/30/25 A Buy

General Counsel

390 0.0004%
12/5/25 A Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
-4.65%+1.62%+19.24%+14.98% 1.31B
-0.19%+2.39%+24.45%-6.10% 68.85B
-0.54%+1.02%+37.33%+189.96% 52.13B
-3.65%+34.50%+34.50%+34.50% 43.46B
-0.58%-0.23%-52.36%-53.82% 41.24B
-1.49%-2.94%+65.37%-26.15% 30.41B
-0.69%-8.47%+98.05%-50.84% 24.53B
-1.80%+1.14%+71.46%+80.49% 23.42B
+3.99%+3.12%+3.87%+200.81% 19.75B
+0.26%+0.39%+72.12%+126.52% 16.57B
Average -0.85%-0.21%+37.40%+51.03% 32.17B
Weighted average by Cap. -0.71%-0.43%+32.12%+45.66%

Financials

2026 *2027 *
Net sales 1.68B 173M 152M 140M 129M 243M 16.67B 247M 657M 8.16B 649M 635M 28.11B 1.87B 193M 169M 156M 144M 272M 18.62B 276M 733M 9.11B 725M 709M 31.4B
Net income 410M 42.32M 37.09M 34.29M 31.54M 59.5M 4.08B 60.46M 161M 2B 159M 155M 6.88B 492M 50.79M 44.51M 41.15M 37.84M 71.4M 4.9B 72.55M 193M 2.4B 191M 187M 8.26B
Net Debt -694M -71.64M -62.79M -58.04M -53.38M -101M -6.91B -102M -272M -3.38B -269M -263M -11.65B -721M -74.42M -65.23M -60.3M -55.46M -105M -7.18B -106M -283M -3.51B -279M -273M -12.1B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
20/07/26 SEK 119.00 -4.65% 276,178
17/07/26 SEK 124.80 +7.59% 598,880
16/07/26 SEK 116.00 -0.34% 376,158
15/07/26 SEK 116.40 -1.02% 97,595
14/07/26 SEK 117.60 +0.43% 70,107
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
124.80SEK
Average target price
165.00SEK
Spread / Average Target
+32.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock